SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 14, 2020
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation)
|(Commission File Number)||(I.R.S. Employer Identification No.)|
180 East Broad St., Columbus, Ohio
|(Address of Principal Executive Offices)||(Zip Code)|
(Registrant's Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 14, 2020, Hexion Inc. issued a news release announcing the return of Craig Rogerson, President and Chief Executive Officer (“CEO”), from medical leave, effective September 14, 2020. George Knight, who served as Acting CEO since March 29, 2020, continues in his previous role as Executive Vice President and Chief Financial Officer. A copy of the News Release is furnished as Exhibit 99.1 to this current report.
Item 9.01 Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|Date:||September 14, 2020||/s/ Douglas A. Johns|
|Douglas A. Johns|
Executive Vice President and General Counsel
FOR IMMEDIATE RELEASE
Hexion Inc. Announces Return of Chairman, President and CEO from Medical Leave
COLUMBUS, Ohio - (September 14, 2020) - Hexion Inc. (“Hexion” or the “Company”) today announced that Craig Rogerson, Chairman, President and Chief Executive Officer (“CEO”), has returned from medical leave effective today.
“I’m pleased to return, and I’d like to acknowledge George Knight and the senior management team for assuming additional duties during my absence,” said Craig Rogerson, Chairman, President and Chief Executive Officer. “I would also like to acknowledge all our associates who continue to safely operate our manufacturing sites and remain focused on serving our customers despite ongoing global challenges due to COVID-19.”
George Knight, who served as Acting CEO, continues in his role as Executive Vice President and Chief Financial Officer.
About the Company
Based in Columbus, Ohio, Hexion Inc. is a global leader in thermoset resins. Hexion Inc. serves the global adhesive, coatings, composites and industrial markets through a broad range of thermoset technologies, specialty products and technical support for customers in a diverse range of applications and industries. Additional information about Hexion Inc. and its products is available at www.hexion.com.
Investors and Media Contact: